Best Available Treatment Study

An international study to evaluate therapeutic options for #PIMS-TS / #MIS-C to help identify which patients to treat and which treatments work.

[Best Available Treatment Study @BATStudy]

@andrew_mcardle  @OrtensiaVito @patel_harsita @DrLECB @PriyenShah86 @clare__wilson @DrCBroderick @rgnijman @AdriTremoulet @DrMunblit @rolandoug
@mjcarterhealth @lizWWyld @acunningID
@jetpackjeth @_myrsini_ @BrodinPetter
@sam_channon

[Best Available Treatment Study @BATStudy]

Pleased to announce that BATS is about to start our 2nd round of analysis of patients with #MISC. Paediatricians around the world have recruited an incredible 2080 patients with PIMS-TS/MIS-C, from over 35 countries. Watch this space!

#IDresearch #dataanalysis

[Eric Topol @EricTopol]

2 new @NEJM observational reports for IVIG +/- steroid treatment of multisystem inflammatory syndrome of children (MIS-C)
1 says it works
1 says it doesn't
+ an insightful @VirusDocDeBiasi editorial for why this may have occurred
https://t.co/iuGOMqQ08V

[Best Available Treatment Study @BATStudy]

@andrew_mcardle @OrtensiaVito @patel_harsita @DrLECB @PriyenShah86 @clare__wilson @DrCBroderick @rgnijman @AdriTremoulet @DrMunblit @rolandoug @mjcarterhealth @lizWWyld @acunningID @jetpackjeth @_myrsini_

[Best Available Treatment Study @BATStudy]

Delighted that our analysis of the first 614 patients enrolled to the study has been published in @NEJM!

https://t.co/85GnYlCQeJ

[Best Available Treatment Study @BATStudy]

We are excited to present our first findings from the BATS study at #ESPID2021 looking at treatment effectiveness in #MIS_C. Can't wait to see you there! @ESPIDsociety

[Vanessa Sancho-Shimizu @SanchoShimizu]

Come join Infection Rounds TODAY
Wednesday 3rd February
16h– 17h
 @ImperialPaeCH @ImperialInfect
James Seddon
The changing landscape of multidrug-resistant tuberculosis in children’

Jethro Herberg
Molecular pathogen testing in febrile children: results from the PERFORM study

[Best Available Treatment Study @BATStudy]

Credit to @andrew_mcardle for the visualisation

[Best Available Treatment Study @BATStudy]

The incredible body of data being collected as part of this study will help us to really understand which treatments work in #PIMS_TS/#MIS_C

Huge thanks to those that have helped recruit over 430 patients!

To find out more and enrol your patients, visit https://t.co/tmmKSq5W5V

[PIPSQC @PIPSQC]

#pedsicu #openpicu #covid19 @apsmunro @damian_roland @covkidproject @npdcoalition @BrodinPetter @BarneyUoB @yoncabulutmd @areinamo21 @daniel_forsha @Nopanaden @ArditiMd @CantillMauricio @LA_Rednetwork @JennaMillerKC @SapnaKmd @DeannaMarie208 @VSLanziotti @sidraishaque @ongsoomay

[Ruud G Nijman @rgnijman]

Please share your cases of #PIMS #MISC with our BATStudy to understand how to best treat: easy online registration and data entry. @PERUKItweep @EAPaediatrics @EuropeanPEM @PERFORM_2020

[Danilo.Buonsenso_Surf4Children @surf4children]

@lizWWyld @BATStudy @acunningID @_myrsini_ @andrew_mcardle @patel_harsita @bpaiig @ESPIDsociety @PICSociety @PICJournalWatch cant wait to see another important result on PIMS, so much needed for daily practice ! thanks a lot for your efforts , thanks to all those leading and contributing ❤️

[Danilo.Buonsenso_Surf4Children @surf4children]

@BATStudy @acunningID ok sorry missed the link! thanks. lot, can’t wait

[Liz Whittaker Wyld @lizWWyld]

@surf4children @BATStudy @acunningID Hi - exciting early analysis underway - watch this space - and upload your patients! @_myrsini_ @andrew_mcardle @patel_harsita @bpaiig @ESPIDsociety @PICSociety @PICJournalWatch

[Best Available Treatment Study @BATStudy]

@surf4children @acunningID Watch this space.

Analysis of data is underway and results will be circulated as soon as they are available.

[Best Available Treatment Study @BATStudy]

Patients have been recruited from 157 sites in the highlighted countries in this truly international effort to identify the best treatments for #PIMS_TS / #MIS_C.

Find out more and start enrolling patients by visiting: https://t.co/kCUxl4pReu

[Rolando Ulloa-Gutierrez @rolandoug]

#MIS_C Síndrome Inflamatorio Multisistémico en Latinoamérica: nuestro estudio #REKAMLATINA3 retrospectivo + prospectivo, vía @PIDJournal. Enrolando y hasta fin de la pandemia. @rekamlatina @GabrielaIvanko1 @AdriTremoulet @adriyock #PIMSTS #pedsID #pedsICU
https://t.co/GjRMDKF3qs

[Best Available Treatment Study @BATStudy]

Clinicians around the world have recruited 399 patients with PIMS-TS/MIS-C into the Best Available Treatment Study to help understand the best treatments for this rare but important new disease in children

To find out more and enrol patients, check out https://t.co/BiKZwZEJf4

[Aubrey Cunnington @acunningID]

With #COVID19 cases rising again, we're expecting more cases of PIMS-TS/MIS-C. We need to find the best treatments for this new condition. Healthcare professionals in 42 countries are already helping to do this in the Best Available Treatment Study https://t.co/lmmZ1e5d2w